EDGAR Filing Documents for 0001193125-09-067689

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001193125-09-067689

Filing Date

2009-03-30

Accepted

2009-03-30 16:19:13

Documents

Period of Report

2008-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	d10k.htm	10-K	771740
2	FORM OF RESTRICTED STOCK GRANT AGREEMENT	dex1039.htm	EX-10.39	38539
3	FORM OF NON-QUALIFIED STOCK OPTION GRANT AGREEMENT	dex1040.htm	EX-10.40	25204
4	FORM OF INCENTIVE STOCK OPTION GRANT AGREEMENT	dex1041.htm	EX-10.41	25848
5	SUBSIDIARY OF PRO PHARMACEUTICALS, INC.	dex211.htm	EX-21.1	2094
6	CONSENT OF DELOITTE & TOUCHE LLP	dex231.htm	EX-23.1	1827
7	CONSENT OF VITALE, CATURANO & COMPANY, PC	dex232.htm	EX-23.2	1937
8	CERTIFICATION OF CEO PURSUANT TO SECTION 302	dex311.htm	EX-31.1	9746
9	CERTIFICATION OF CFO PURSUANT TO SECTION 302	dex312.htm	EX-31.2	9756
10	CERTIFICATION OF CEO PURSUANT TO SECTION 906	dex321.htm	EX-32.1	4859
11	CERTIFICATION OF CFO PURSUANT TO SECTION 906	dex322.htm	EX-32.2	4845
	Complete submission text file	0001193125-09-067689.txt		897802

Mailing Address 189 WELLS ST STE 200 NEWTON MA 02459

Business Address 189 WELLS ST STE 200 NEWTON MA 02459 6175590033

PRO PHARMACEUTICALS INC (Filer) CIK: 0001133416 (see all company filings)